Showing results (451-460 of 512) with videos related to
Sort By:
Pageof 52
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 16, 2021
Low- vs. high-dose radiotherapy in Graves' ophthalmopathy: a retrospective comparison of long-term resultsThomas Weissmann, Sebastian Lettmaier, Anna-Jasmina Donaubauer, et al.Journal of Clinical Medicine|May 28, 2022
Factors Influencing the Outcome of Head and Neck Cancer of Unknown Primary (HNCUP)Matthias Balk, Robin Rupp, Konstantinos Mantsopoulos, et al.Ear, Nose, & Throat Journal|December 9, 2024
Symptom Burden and Quality of Life in Long-Term Survivors with Head and Neck CancerMagdalena Gostian, Moritz Allner, Atina Rak, et al.Nature Communications|August 2, 2022
Steering the multiexciton generation in slip-stacked perylene dye array via exciton couplingYongseok Hong, Maximilian Rudolf, Munnyon Kim, et al.International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|June 8, 2022
Detailed in vitro analyses of the impact of multimodal cancer therapy with hyperthermia and radiotherapy on the immune phenotype of human glioblastoma cellsEileen Stoll, Michael Hader, Michael Rückert, et al.Oncotarget|August 6, 2016
Spatial distribution of FoxP3+ and CD8+ tumour infiltrating T cells reflects their functional activityRebecca Posselt, Katharina Erlenbach-Wünsch, Matthias Haas, et al.European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|October 5, 2019
Single-cycle induction chemotherapy before chemoradiotherapy or surgery in functionally inoperable head and neck squamous cell carcinoma: 10-year resultsMarius Breheret, Dorota Lubgan, Marlen Haderlein, et al.International Journal of Molecular Sciences|September 10, 2021
Hypofractionated Radiotherapy Upregulates Several Immune Checkpoint Molecules in Head and Neck Squamous Cell Carcinoma Cells Independently of the HPV Status While ICOS-L Is Upregulated Only on HPV-Positive CellsSebastian Wimmer, Lisa Deloch, Michael Hader, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 13, 2022
Tumor-specific radiosensitizing effect of the ATM inhibitor AZD0156 in melanoma cells with low toxicity to healthy fibroblastsJulian Scheper, Laura S Hildebrand, Eva-Maria Faulhaber, et al.Neoplasia (New York, N.Y.)|January 25, 2023
Identification and characterization of circular RNAs as novel putative biomarkers to predict anti-PD-1 monotherapy response in metastatic melanoma patients - Knowledge from two independent international studiesJian-Guo Zhou, Rui Liang, Hai-Tao Wang, et al.Pageof 52